Catalyst Biosciences, Inc. announced the appointment of Clinton Musil as its new chief financial officer, effective July 1, 2020. Clinton Musil previously held the position of Chief Business Officer at Personalis, where he helped build a pipeline and rapidly scale revenue as well as complete the Company's $150 million initial public listing.